Navigation Links
Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
Date:5/15/2008

Location: W375E

Lobby

Poster 3 Poster

Awarded a Foundation Merit Award discussion

12:00-1:00 p.m.

Location: W375A

E7080 Phase I dose escalation study May 31, 2008

Abstract No: 3527 and biomarker analysis of 8:00 a.m.

E7080 in patients with -12:00 p.m.

advanced solid tumors Location: W375E

Poster 4 Lobby

Poster

discussion

12:00-1:00 p.m.

Location: W375A

Cutaneous T-cell (Integrated analysis of three May 31, 2008

Lymphoma large Phase III trials in CTCL) 8:00 a.m.

Abstract No: 8551 Poster 45A -12:00 p.m.

Location: S Hall

A1

MORAb-003 A Phase I Study of MORAb-003, May 31, 2008

(farletuzumab) a Humanized Monoclonal Antibody 2:00-6:00 p.m.

Abstract No: 5517 Against Folate Receptor Alpha, Location: S403

in Advanced Epithelial Poster

Ovarian Cancer discussion

Poster 7 5:00-6:00 p.m.


'/>"/>

SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GeoVax Secures $10 Million Financing Commitment
2. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
3. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
4. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
5. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
6. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
7. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
10. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
11. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced ... four weeks for the first dose cohort, 200 mg bid, ... with pegylated interferon and ribavirin (SOC) in HCV patients. ... of virus (<15 IU/ml) at week 4, known as ... compared to 20% of patients receiving placebo plus SOC. ...
(Date:12/17/2009)... Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX ... to Vice President, Sales and Commercial Affairs. ... Lauterbach will be responsible for all commercial activities, ... in accordance with the collaboration agreement between the ... other products that emerge from the Company,s pipeline. ...
(Date:12/16/2009)... Today, a group of national medical societies launched a ... Patient Protection and Affordable Care Act, currently under consideration ... a final vote in the coming days. The ... against a health care bill that is "bad medicine" ... our health care system needs reform - but the ...
Breaking Medicine Technology:ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Physician Groups Oppose Current Senate Health Care Reform Bill 2Smoking during pregnancy puts children at risk of psychotic symptoms 58612 1Smoking during pregnancy puts children at risk of psychotic symptoms 58612 2Platelet rich plasma 3A Does it work 3F 58610 1Platelet rich plasma 3A Does it work 3F 58610 2Platelet rich plasma 3A Does it work 3F 58610 3Strategy outlined for growing bioenergy while protecting wildlife 10204 1
... Amgen,(Nasdaq: AMGN ) and Millennium: ... Company Limited (TSE: 4052), today announced that,enrollment in ... 706) in,combination with paclitaxel and carboplatin for the ... has been temporarily suspended,following a planned safety data ...
... a contract development and,manufacturing organization for sterile filling, ... facility in Delaware. Isogen was founded to,specifically address ... the $2 billion highly-niched, low-volume clinical and,early-stage commercial ... Companies can invest over $100 ...
Other Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Isogen Launches Major New Facility to Address Global Biopharma Demand 2
(Date:12/17/2009)... Dec. 17 The recently opened ... out in the community in full force this holiday ... on December 13th, benefiting the Arthritis Foundation, a non-profit ... arthritis. The event boasted 1,500 attendees, spotlighting LSI,s passion ... is a renowned, national fundraiser and a festive way ...
(Date:12/17/2009)... University of Jerusalem Kuvin Center for the Study ... $5 million grant from the Bill & Melinda ... Ethiopia. , The project will be led by ... the Institute of Medical Research Israel-Canada at the ... entitled ,Studies on the ecology and transmission dynamics ...
(Date:12/17/2009)... How Exercise Has Helped, Healed, and Preserved Good Health ... ... Racquet & Sportsclub Association (IHRSA) announced today that as part of ... all ages and abilities to make 2010 the year we unite ... America wherein regular daily exercise is highly valued and widely practiced. ...
(Date:12/17/2009)... to perform fill/finish of nimotuzumab , ... ... and CEO of Therapure Biopharma Inc. and David Allan, Chairman ... of an agreement under which Therapure Biopharma will provide aseptic ... licensed to YM’s majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by ...
(Date:12/17/2009)... Abaxis, Inc. (Nasdaq: ABAX ), ... instruments and rapid tests for the medical, research ... entered the production animal diagnostics marketplace with its ... This is a USDA-licensed test for Avian Influenza ... ducks. The disposable, non-instrumented device, providing results in ...
Breaking Medicine News(10 mins):Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:Hebrew U. receives $5 million for research on leishmaniasis in Ethiopia 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 2Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 3Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 4Health News:IHRSA's Campaign for a Healthier America Calls on All Americans to Curtail Health Care Costs in 2010 by Becoming Physically Active 5Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 2Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 3Health News:Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership 4Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4
... Mich., Oct. 3 WHNN radio personality,Bob Hughes, a well-known ... Mobile Care Hearing which is moving to Saginaw this,month. ... Rock ,n,Roll music and the quality of my life has ... devices at Mobile Care Hearing,",says Hughes. "I am really enjoying ...
... 3 Pink tags will be on display,throughout Food ... as the,supermarket chain partners with vendors and suppliers to ... the month, pink tags can be found on shelves ... Nevada and Foods Co stores in,Central and Northern California ...
... 3 President Bush,s veto today,of a bill ... of,children from families with low incomes creates a ... says Oral Health America, a national,advocacy organization. President ... children eligible for coverage through a,bipartisan, bicameral agreement ...
... AIRES, Argentina, October 3, 2007 The first reported ... more than two-thirds of patients with moderate to severe ... achieved at least a 75 percent reduction in psoriasis ... as measured by the Psoriasis Area and Severity Index ...
... The Stop & Shop Supermarket,Company, Giant Food and General ... for the Cure with the Pink for the Cure Program. ... Shop/Giant,Consumer Advisor Andrea Astrachan, "and by purchasing ,Pink for the ... the fight against,breast cancer and help us donate to this ...
... Nurses,Association/National Nurses Organizing Committee today condemned President,Bush,s veto of ... "Listening to the overheated rhetoric coming out of ... gone but his legacy lives on," said Zenei,Cortez, RN, ... for his recent claims that legislators who passed the ...
Other Medicine News:Health News:WHNN's Bob Hughes Fitted With Hearing Aids by Mobile Care Hearing Clinic Now Serving Saginaw Area 2Health News:Food 4 Less/Foods Co 'Pink Tag' Campaign to Raise $150,000 for Breast Cancer Awareness in October 2Health News:SCHIP Veto a Big Cavity for Children's Oral Healthcare, Advocates Say 2Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 2Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 3Health News:Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis 4Health News:Stop & Shop and Giant Food Join General Mills in Pink for the Cure 2Health News:California Nurses Association Blasts Bush for Veto on Children's Health 2
... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...
The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...
... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...
Medicine Products: